Matches in DBpedia 2015-04 for { <http://dbpedia.org/resource/Bicalutamide> ?p ?o }
- Bicalutamide abstract "Bicalutamide (Casodex, Cosudex, Calutide, Kalumid) is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism. It was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease.Bicalutamide is marketed by AstraZeneca and several companies selling generic versions. It can be used as monotherapy or in combination with a gonadotropin-releasing hormone (GnRH) agonist or surgical castration.".
- Bicalutamide atcPrefix "L02".
- Bicalutamide atcSuffix "BB03".
- Bicalutamide casNumber "90357-06-5".
- Bicalutamide drugbank "DB01128".
- Bicalutamide fdaUniiCode "A0Z3NAU9DP".
- Bicalutamide iupacName "N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide".
- Bicalutamide pubchem "2375".
- Bicalutamide thumbnail Bicalutamide.svg?width=300.
- Bicalutamide wikiPageExternalLink 5_82.aspx.
- Bicalutamide wikiPageExternalLink casodex.pdf.
- Bicalutamide wikiPageID "1269496".
- Bicalutamide wikiPageRevisionID "637897638".
- Bicalutamide atcPrefix "L02".
- Bicalutamide atcSuffix "BB03".
- Bicalutamide bioavailability "well absorbed".
- Bicalutamide c "18".
- Bicalutamide casNumber "90357".
- Bicalutamide chembl "63560".
- Bicalutamide chemspiderid "2284".
- Bicalutamide drugbank "DB01128".
- Bicalutamide eliminationHalfLife "501120.0".
- Bicalutamide f "4".
- Bicalutamide h "14".
- Bicalutamide hasPhotoCollection Bicalutamide.
- Bicalutamide image "Bicalutamide ball-and-stick.png".
- Bicalutamide inchi "1".
- Bicalutamide inchikey "LKJPYSCBVHEWIU-UHFFFAOYAZ".
- Bicalutamide iupacName "N-[4-cyano-3-phenyl]-3-[sulfonyl]-2-hydroxy-2-methylpropanamide".
- Bicalutamide iupharLigand "2863".
- Bicalutamide kegg "D00961".
- Bicalutamide legalStatus "Rx-only".
- Bicalutamide medlineplus "a697047".
- Bicalutamide metabolism Liver.
- Bicalutamide molecularWeight "430.373".
- Bicalutamide n "2".
- Bicalutamide o "4".
- Bicalutamide pdbLigand "198".
- Bicalutamide pregnancyUs "X".
- Bicalutamide proteinBound "96.0".
- Bicalutamide pubchem "2375".
- Bicalutamide routesOfAdministration "Oral".
- Bicalutamide s "1".
- Bicalutamide smiles "O=CCCSc2ccccc2".
- Bicalutamide stdinchi "1".
- Bicalutamide stdinchikey "LKJPYSCBVHEWIU-UHFFFAOYSA-N".
- Bicalutamide tradename "Casodex".
- Bicalutamide unii "A0Z3NAU9DP".
- Bicalutamide verifiedfields "changed".
- Bicalutamide verifiedrevid "459978482".
- Bicalutamide subject Category:Alcohols.
- Bicalutamide subject Category:Anilides.
- Bicalutamide subject Category:Antiandrogens.
- Bicalutamide subject Category:Nitriles.
- Bicalutamide subject Category:Organofluorides.
- Bicalutamide subject Category:Sulfones.
- Bicalutamide type Abstraction100002137.
- Bicalutamide type Agent114778436.
- Bicalutamide type Alcohol107884567.
- Bicalutamide type Alcohols.
- Bicalutamide type Beverage107881800.
- Bicalutamide type CausalAgent100007347.
- Bicalutamide type Chemical114806838.
- Bicalutamide type Compound114818238.
- Bicalutamide type Drug103247620.
- Bicalutamide type DrugOfAbuse103248958.
- Bicalutamide type Fluid114939900.
- Bicalutamide type Food100021265.
- Bicalutamide type Liquid114940386.
- Bicalutamide type Material114580897.
- Bicalutamide type Matter100020827.
- Bicalutamide type Nitrile114827346.
- Bicalutamide type Nitriles.
- Bicalutamide type OrganicCompound114727670.
- Bicalutamide type Part113809207.
- Bicalutamide type PhysicalEntity100001930.
- Bicalutamide type Relation100031921.
- Bicalutamide type Substance100019613.
- Bicalutamide type Substance100020090.
- Bicalutamide type Drug.
- Bicalutamide type DrugProduct.
- Bicalutamide type Thing.
- Bicalutamide type Q8386.
- Bicalutamide comment "Bicalutamide (Casodex, Cosudex, Calutide, Kalumid) is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism. It was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease.Bicalutamide is marketed by AstraZeneca and several companies selling generic versions.".
- Bicalutamide label "Bicalutamida".
- Bicalutamide label "Bicalutamide".
- Bicalutamide label "Bicalutamide".
- Bicalutamide label "Bicalutamide".
- Bicalutamide sameAs Bicalutamide.
- Bicalutamide sameAs Bicalutamide.
- Bicalutamide sameAs Bicalutamida.
- Bicalutamide sameAs m.04nty7.
- Bicalutamide sameAs Q1988832.
- Bicalutamide sameAs Q1988832.
- Bicalutamide sameAs Bicalutamide.
- Bicalutamide sameAs DB01128.
- Bicalutamide sameAs 2375.
- Bicalutamide sameAs Bicalutamide.
- Bicalutamide wasDerivedFrom Bicalutamide?oldid=637897638.
- Bicalutamide depiction Bicalutamide.svg.